PMA P210026

Device
Ki-67 IHC MIB-1 pharmDx (Dako Omnis)
Applicant
Agilent Technologies, Inc.
PMA number
P210026
Product code
QQT
Decision date
2026-09-11
Generic name
Immunohistochemistry assay, antibody, Ki-67
Approval order statement
approval of manufacturing process and equipment changes for filling and capping

Current openFDA PMA Record#

Device
Ki-67 IHC MIB-1 pharmDx (Dako Omnis)
Applicant
Agilent Technologies, Inc.
PMA number
P210026
Supplement
S003
Product code
QQT
Generic name
Immunohistochemistry assay, antibody, Ki-67
Decision date
2026-09-11
Decision code
OK30
Date received
2026-08-14
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
approval of manufacturing process and equipment changes for filling and capping